Diagnosis → Neurology/Neurosurgery
Cerebral venous sinus thrombosis
Thrombosis in the cerebral venous sinus.
Also known as: Cavernous sinus thrombosis, Cerebral sinus venous thrombosis, Cerebral vein thrombosis, Cerebral venous thrombosis, Dural venous sinus thrombosis, Intracranial venous thrombosis
Etiology
Cause [ac3]
Thrombophilia:
Genetic: factor V Leiden mutation, prothrombin mutation, antithrombin III deficiency, protein C or S deficiency, and elevated factor VIII levels
Acquired: antiphospholipid antibody syndrome, hyperhomocysteinemia, heparin-induced thrombocytopenia, obesity, severe dehydration, estrogen exposure, pregnancy, nephrotic syndrome, and sickle cell disease
Aseptic causes: Trauma, surgery, systemic inflammatory disease
Drugs: Corticosteroids, L-asparaginase, chemotherapy
Infections primarily within the nasolabial triangle:
Orbital cellulitis, pharyngitis, abscess formation, cellulitis, sphenoid or ethmoid sinusitis, otitis media, mastoiditis, dental infection (tooth extractions), maxillofacial surgery, meningitis
Agent: Staphylococcus aureus (66%), Streptococcus species (20%), pneumococcus (5%), Gram-negative species (Proteus, Haemophilus, Pseudomonas, Fusobacterium, and Bacteroides), gram-positive species (Corynebacterium and Actinomyces), non-bacterial (VZV, HIV, fungal mucormycosis)
Pathophysiology
Thrombotic stimuli (adjacent infection, embolization, thrombophilia) --> thrombosis
↑ venous/capillary hydrostatic pressure upstream → vasogenic edema
If venous pressure approaches arterial pressure → ↓ arterial inflow → venous infarction
Anatomic subtypes:
Cortical and Deep cerebral venous thrombosis --> Intracranial venous system:
Intracranial hypertension, venous infarction, and/or intracranial hemorrhage
Dural venous sinus thrombosis --> Meninges
Cavernous sinus thrombosis --> Facial structures:
Facial and periorbital edema, ptosis, proptosis, chemosis, discomfort, pain with eye muscle movement, papilledema, retinal venous distension, and loss of vision
Risk factors [ac3]
Facial infections
Thrombophilia
Malignancy
Autoimmune/inflammatory disease
Head trauma
Dehydration
Immunosuppression (diabetes mellitus, steroids, cancer, and chemotherapy)
Pregnancy
Estrogen exposure
Complications
Intracranial hemorrhage
Hemorrhagic venous infarction
Stroke
Seizures/epilepsy
Visual loss
Diplopia
Return-to-work issues: headache/fatigue/cognitive issues
Epidemiology
Incidence per 100.000 [ac3][s6h][vgf][1d2]
Default
Symptoms & findings
Symptoms
Confusion, Decreased consciousness, Diplopia, Fever, Headache, Hemiplegia, Intraocular hemorrhage, Nausea, Ophthalmoplegia, Seizure, Visual disturbances
Clinical findings
Anamneses
None listed.
Localized findings
Approach
Blood test: WBC, CRP, erythrocyte sedimentation rate (ESR), and D-dimer
CT venography
MR venography
Lumbar puncture
Treatment
Stabilize ABCs [p2v]
Manage elevated ICP
Treat seizures
Therapeutic anticoagulation (LMWH, later oral) unless clear contraindication
Address provoking cause(s) immediately
Stop estrogen, treat infection, evaluate malignancy, hydration
Antibiotics for 3-4 weeks [ac3]
Anti-staphylococcal agent (Vancomycin)
Third-generation cephalosporin
Metronidazole (for anaerobic coverage)
Antifungal treatment (Amphotericin B)
Corticosteroid
Thrombolysis/thrombectomy in selected patients failing anticoagulation
Surgical intervention in selective patients:
Sphenoidectomy
Ethmoidectomy
Maxillary antrostomy
Mastoidectomy
Abscess drainage
Craniotomy for subdural empyema or brain abscess
Orbital decompression
Ventricular shunt placement
Extensive sinus debridement due to mucormycosis
Differential diagnoses
Aspergillosis, Brain tumor, Carotid artery dissection, Carotid cavernous fistula, Cellulitis, Intracranial hemorrhage, Meningioma, Meningitis, Metastatic bone tumors, Migraine, Sarcoidosis, Stroke, Subarachnoid hemorrhage, Syphilis, Tuberculosis
References
[1] Plewa MC, Hall WA. Cavernous Sinus Thrombosis. [Updated 2025 Jun 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448177/
[2] Zhou LW, Yu AYX, Ngo L, Hill MD, Field TS. Incidence of Cerebral Venous Thrombosis: A Population-Based Study, Systematic Review, and Meta-Analysis. Stroke. 2023 Jan;54(1):169-177.
[3] Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral Venous Sinus Thrombosis Incidence Is Higher Than Previously Thought: A Retrospective Population-Based Study. Stroke. 2016 Sep;47(9):2180-2.
[4] Rezoagli E, Bonaventura A, Coutinho JM, Vecchié A, Gessi V, Re R, Squizzato A, Pomero F, Bonzini M, Ageno W, Dentali F. Incidence Rates and Case-Fatality Rates of Cerebral Vein Thrombosis: A Population-Based Study. Stroke. 2021 Nov;52(11):3578-3585.
[5] Saposnik G, Bushnell C, Coutinho JM, Field TS, Furie KL, Galadanci N, Kam W, Kirkham FC, McNair ND, Singhal AB, Thijs V, Yang VXD; American Heart Association Stroke Council; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular and Stroke Nursing; and Council on Hypertension. Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association. Stroke. 2024 Mar;55(3):e77-e90.